DMD Advocates Advised Molbio Diagnostics On $30 Million Investment In Optrascan

DMD Advocates Advised Molbio Diagnostics On $30 Million Investment In Optrascan

DMD Advocates advised Molbio Diagnostics on its $30 million investment for acquiring a majority stake in OptraSCAN Inc., a US-based company specializing in digital pathology solutions.

This acquisition enables Molbio to integrate OptraSCAN’s technology into its portfolio, strengthening its position in the diagnostics market both in India and internationally. For OptraSCAN, the deal provides capital for growth and expansion while aligning its operations with Molbio’s strategic direction. This partnership enhances the capabilities of both companies, drives innovation, and increases their competitive edge in the healthcare and diagnostics sectors.

The transaction at DMD Advocates was led by Partner Ayesha Rai, along with Principal Associate Pooja Shah and Associate Vanshikha Choraria. The legal due diligence team consisted of Counsel Kajal Tandon, Associates Luv Madan, Parizad Irani, and Tarush Bhandari.

Senior Partner & Head of Corporate Rashi Dhir and Lead Partner Vihang Virkar provided crucial inputs on the transaction.

DMD Advocates worked with Partner Ryan Roberts from Roberts Zimmerman PLLC, a Texas-based law firm, for US law-related matters.